25 research outputs found

    Caracterización molecular de aislados de "Mycobacterium avium" subespecie "paratuberculosis"

    Get PDF
    Tesis de la Universidad Complutense de Madrid, Facultad de Veterinaria, Departamento de Sanidad Animal, leída el 09-07-2010Depto. de Sanidad AnimalFac. de VeterinariaTRUEpu

    El IVA en la venta de energía eléctrica

    Get PDF
    <div><p>Non-small cell lung cancer (NSCLC) patients treated with small molecule <i>EGFR</i> inhibitors, such as gefitinib, frequently develop drug resistance due to the presence of secondary mutations like the T790M mutation on <i>EGFR</i> exon 20. These mutations may originate from small subclonal populations in the primary tumor that become dominant later on during treatment. In order to detect these low-level DNA variations in the primary tumor or to monitor their progress in plasma, it is important to apply reliable and sensitive mutation detection methods. Here, we combine two recently developed methodologies, <u>Di</u>fferential <u>S</u>trand <u>Se</u>paration at <u>C</u>ritical <u>T</u>emperature (DISSECT), with peptide nucleic acid-locked nucleic acid (PNA-LNA) polymerase chain reaction (PCR) for the detection of T790M <i>EGFR</i> mutation. DISSECT pre-enriches low-abundance T790M <i>EGFR</i> mutations from target DNA prior to implementing PNA-LNA PCR, a method that can detect 1 mutant allele in a background of 100–1000 wild type alleles. The combination of DISSECT and PNA-LNA PCR enables the detection of 1 mutant allele in a background of 10,000 wild type alleles. The combined DISSECT-PNA-LNA PCR methodology is amenable to adaptation for the sensitive detection of additional emerging resistance mutations in cancer.</p></div

    T790M<i>EGFR</i> mutant enrichment analysis by HRM and Sanger Sequencing.

    No full text
    <p>(A) HRM analysis plots and Sanger Sequencing chromatograms of serial dilutions of T790M <i>EGFR</i> mutations versus wild type DNA following conventional PCR. (B) The detection after mutant enrichment by conventional PNA-LNA PCR using an initial mutant abundance of 1% and 0.1% T790M, c.2369C>T. (C) Improved detection after mutant enrichment from two rounds of DISSECT followed by conventional PNA-LNA PCR from an initial mutant abundance of 1% and 0.01% T790M, c.2369C>T.</p

    Schematic of procedure.

    No full text
    <p>(A) Flowchart diagram of <i>EGFR</i> exon 20 mutant enrichment by DISSECT followed by PNA-LNA PCR. (B) Schematic design of <i>EGFR</i> exon 20 primers, LNA probe, and PNA clamp during PNA-LNA PCR procedure.</p

    Temperature-tolerant-fast-COLD-PCR in emulsion: Overview of the steps involved.

    No full text
    <p>Multiplex pre-amplification from genomic DNA; emulsification with gene-specific primers; mixing into a single tube; and temperature-tolerant emulsion-based fast-COLD-PCR.</p

    Comparison of PNA-LNA sensitivity of detection for the T790M<i>EGFR</i> mutation.

    No full text
    <p>(A) Real-time PCR plot represents serially diluted PCR product with T790M mutation (1%, 0.1% and 0.01%) into amplified product from wild type DNA, by conventional PNA-LNA PCR. (A, right) Corresponding plot of the log concentration of T790M mutant DNA versus threshold cycle number. Graph shows mutant T790M serial dilution following conventional PNA-LNA PCR. (B) Real-time PCR plot shows an increased level of detection when PNA-LNA is applied to a sample that has undergone two rounds of mutant enrichment by DISSECT. (B, right) Corresponding graph shows mutant T790M serial dilution following PNA-LNA PCR after DISSECT.</p
    corecore